Efficient assessment of drug safety and toxicity can be a complex and time-consuming matter. We develop and deliver integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates.
Learn more about our Safety ServicesWe combine our cardiovascular knowledge with expertise in hiPSC-derived cardiomyocyte manufacturing to offer you predictive and translational in vitro disease models, as well as assays for efficacy screening at any throughput.
Learn more about our Efficacy services
Stefan is the Chief Executive Officer of Ncardia. He obtained his MSc and PhD (both cum laude) in stem cell biology under the supervision of Prof. Dr Mummery, and brings over a decade of experience in stem cell research and product development. As key inventor of the underlying Pluriomics technologies he has been instrumental in the establishment and growth of the company.
Roman is our Director of BD & Sales in Europe. He has a background in biology and has gained commercial experience in the stem cell industry. He is the direct contact person for our German-speaking customers.
Celine is Director of Strategic Alliances & Partnering. After completing her PhD in immunology and molecular biology she moved to business development and developed several successful partnerships with Biotech and Pharma.
Felix is VP Sales & Business Development. He obtained an MBA at the University of Cambridge and has extensive commercial experience in the stem cell market and drug discovery.
Mieke is Product Marketing Manager at Ncardia. She holds a PhD obtained at the Laboratory for Molecular Stem Cell Biology at the Heinrich-Heine University of Dusseldorf, and has extended commercial and marketing experience from several leading biotech companies.
Alexandre has over 15 years' experience in the biotech industry where he occupied various functions. At Ncardia he is responsible for Sales and Business Development of our products and services in Southern Europe.
Tessa has extensive expertise in hiPSC-derived cardiac cells, and cell-based assays for drug safety and efficacy screenings. She has completed her Masters in Bio-Pharmaceutical Sciences at Leiden University and leverages her expertise supporting partners and customers in performing their assays.
Ralf has extended expertise in hiPSC-derived cardiac cells, and cell-based assays for drug safety and efficacy screenings. He obtained his PhD from the University of Bonn, where he focused on aortic vascular smooth muscle cells. With over 16 years of experience with pluripotent stem cell-derived cardiomyocytes, he uses this knowledge in supporting our customers and partners.
Thomas is our Marketing Manager. He obtained his PhD from the University of Cologne. At Ncardia he is responsible for organizing all marketing activities.
Silvina obtained her PhD in neurobiology. She gained experience in applied solutions for the pharmaceutical industry while working at Galapagos and Charles River. As a Project Manager at Ncardia, she uses her experience in our Safety and Efficacy Services that we offer to our customers.
Bernd is the Chief Operating Officer of Ncardia. He obtained his PhD from the University of Cologne and has worked in the TV and Media industries in management positions within the Marketing Departments and Executive Boards, after which he took over the CFO and COO positions at Axiogenesis AG. At Ncardia he is in charge of Operational Affairs (Production, Marketing, Sales, etc).”
Dietmar is the neuroscience specialist at Ncardia. In combination with his electrophysiology expertise, he has the knowledge to support our customers using neural cells.
Charlotte is our Head of Logistics. Her background in industrial management and economic psychology has helped extend superior commercial team customer services in logistics, order processing and post-sales customer services throughout the industry.
Heather joins our US team as Business Development Manager. She has extensive experience in the area of stem cell technologies and sales, which further strengthens Ncardia's presence in the US market.
Below is a selection of our latest news, and the events where you can meet us.
| Sep 29 - Sep 29 | |
| Washington, DC |
| Sep 30 - Oct 03 | |
| Washington, DC |
| Oct 04 - Oct 05 | |
| Munich, Germany |
| Nov 03 - Nov 07 | |
| San Diego, California |
| Nov 07 - Nov 09 |
| Nov 27 - Nov 30 | |
| Lisbon, Portugal |
Be inspired by a selection of our latest innovations.
